Landau et al. sampled leukemia cells from 18 CLL patients at two time points, revealing that SF3B1 and TP53 mutations are late events in subclonal tumor cells (Landau et al., 2013). This evidence concerns the gene SF3B1 and B-cell chronic lymphocytic leukemia.